Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	isocitrate dehydrogenase [NAD(P)+] activity	IDH1 IDH2 IDH3A	3.13e-06	5	137	3	GO:0004448
GeneOntologyMolecularFunction	isocitrate dehydrogenase (NADP+) activity	IDH1 IDH2	4.67e-05	2	137	2	GO:0004450
GeneOntologyMolecularFunction	DNA (cytosine-5-)-methyltransferase activity, acting on CpN substrates	DNMT3A DNMT3B	4.67e-05	2	137	2	GO:0051719
GeneOntologyMolecularFunction	solute:monoatomic cation symporter activity	SLC12A8 SLC13A2 SLC6A1 SLC6A7 SLC39A12 SLC18A2	1.72e-04	119	137	6	GO:0015294
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC9A9 SLC25A42 SLC12A8 SLC13A2 SLC6A1 SLC6A7 SLC39A12 SLC18A2 SLC9A7	2.09e-04	296	137	9	GO:0015291
GeneOntologyMolecularFunction	DNA (cytosine-5-)-methyltransferase activity	DNMT3A DNMT3B	2.78e-04	4	137	2	GO:0003886
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	SLC9A9 SLC12A8 SLC13A2 SLC6A1 SLC6A7 SLC39A12 SLC18A2 MMGT1 SLC9A7 KCNN4 KCNMB3	3.69e-04	465	137	11	GO:0046873
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	SLC25A27 SLC9A9 SLC12A8 SLC13A2 RHAG SLC6A1 SLC6A7 SLC39A12 SLC18A2 MMGT1 SLC9A7 KCNN4 KCNMB3	3.86e-04	627	137	13	GO:0022890
GeneOntologyMolecularFunction	transporter activity	TMEM30B SLC25A27 SLC9A9 SLC25A42 SLC38A9 SLC12A8 SLC13A2 RHAG SLC6A1 SLC6A7 SLC39A12 SLC18A2 MMGT1 SLC9A7 KCNN4 TMEM30A MFSD8 KCNMB3 SLC7A5P1 SLC27A4	5.06e-04	1289	137	20	GO:0005215
GeneOntologyMolecularFunction	chloride:monoatomic cation symporter activity	SLC12A8 SLC6A1 SLC18A2	5.06e-04	23	137	3	GO:0015377
GeneOntologyMolecularFunction	symporter activity	SLC12A8 SLC13A2 SLC6A1 SLC6A7 SLC39A12 SLC18A2	5.96e-04	150	137	6	GO:0015293
GeneOntologyMolecularFunction	N,N-dimethylaniline monooxygenase activity	FMO1 FMO6P	6.88e-04	6	137	2	GO:0004499
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	SLC25A27 SLC9A9 SLC12A8 SLC13A2 RHAG SLC6A1 SLC6A7 SLC39A12 SLC18A2 MMGT1 SLC9A7 KCNN4 MFSD8 KCNMB3	7.25e-04	758	137	14	GO:0015318
GeneOntologyMolecularFunction	monoatomic anion:monoatomic cation symporter activity	SLC12A8 SLC6A1 SLC18A2	7.32e-04	26	137	3	GO:0015296
GeneOntologyMolecularFunction	NADP binding	DPYD FMO1 IDH1 CRYZ	8.69e-04	62	137	4	GO:0050661
GeneOntologyMolecularFunction	aminophospholipid flippase activity	TMEM30B TMEM30A	9.59e-04	7	137	2	GO:0015247
GeneOntologyMolecularFunction	DNA-methyltransferase activity	DNMT3A DNMT3B	9.59e-04	7	137	2	GO:0009008
GeneOntologyMolecularFunction	active monoatomic ion transmembrane transporter activity	SLC9A9 SLC12A8 SLC13A2 SLC6A1 SLC6A7 SLC39A12 SLC18A2 SLC9A7	1.13e-03	301	137	8	GO:0022853
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC9A9 SLC13A2 SLC6A1 SLC6A7 SLC18A2 SLC9A7	1.18e-03	171	137	6	GO:0015081
GeneOntologyMolecularFunction	transmembrane transporter activity	SLC25A27 SLC9A9 SLC25A42 SLC38A9 SLC12A8 SLC13A2 RHAG SLC6A1 SLC6A7 SLC39A12 SLC18A2 MMGT1 SLC9A7 KCNN4 MFSD8 KCNMB3 SLC7A5P1 SLC27A4	1.19e-03	1180	137	18	GO:0022857
GeneOntologyMolecularFunction	mannosyl-oligosaccharide 1,2-alpha-mannosidase activity	MAN1A1 MAN1A2	1.27e-03	8	137	2	GO:0004571
GeneOntologyMolecularFunction	NAD binding	IDH1 IDH2 IDH3A CRYZ	1.60e-03	73	137	4	GO:0051287
GeneOntologyMolecularFunction	amine transmembrane transporter activity	RHAG SLC18A2	1.63e-03	9	137	2	GO:0005275
GeneOntologyMolecularFunction	arginine binding	SLC38A9 CASTOR2	1.63e-03	9	137	2	GO:0034618
GeneOntologyMolecularFunction	chloride transmembrane transporter activity	SLC25A27 SLC12A8 SLC6A1 SLC18A2 MFSD8	1.72e-03	125	137	5	GO:0015108
GeneOntologyMolecularFunction	organic acid:sodium symporter activity	SLC13A2 SLC6A1 SLC6A7	1.76e-03	35	137	3	GO:0005343
GeneOntologyMolecularFunction	mannosyl-oligosaccharide mannosidase activity	MAN1A1 MAN1A2	2.03e-03	10	137	2	GO:0015924
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	SLC25A27 SLC9A9 SLC12A8 SLC13A2 SLC6A1 SLC6A7 SLC39A12 SLC18A2 MMGT1 SLC9A7 KCNN4 KCNMB3	2.09e-03	664	137	12	GO:0008324
GeneOntologyMolecularFunction	solute:sodium symporter activity	SLC13A2 SLC6A1 SLC6A7 SLC18A2	2.35e-03	81	137	4	GO:0015370
GeneOntologyMolecularFunction	organic cation transmembrane transporter activity	SLC25A42 SLC38A9 RHAG SLC6A7	2.56e-03	83	137	4	GO:0015101
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen	FMO1 CYP4F2 FMO6P	2.59e-03	40	137	3	GO:0016709
GeneOntologyMolecularFunction	oxidoreductase activity, acting on CH-OH group of donors	CYP4F2 AKR1A1 IDH1 IDH2 IDH3A	2.64e-03	138	137	5	GO:0016614
GeneOntologyBiologicalProcess	tricarboxylic acid metabolic process	ACLY IDH1 IDH2 IDH3A	5.46e-06	18	138	4	GO:0072350
GeneOntologyBiologicalProcess	isocitrate metabolic process	IDH1 IDH2 IDH3A	5.78e-06	6	138	3	GO:0006102
GeneOntologyBiologicalProcess	dicarboxylic acid metabolic process	GAD2 ACLY IDH1 IDH2 IDH3A KYAT3 ALDH4A1	9.80e-06	111	138	7	GO:0043648
GeneOntologyBiologicalProcess	2-oxoglutarate metabolic process	IDH1 IDH2 IDH3A KYAT3	1.05e-05	21	138	4	GO:0006103
GeneOntologyBiologicalProcess	organic acid catabolic process	GAD2 AMT FMO1 LONP2 CYP4F2 AKR1A1 ADIPOQ KYAT3 ALDH4A1 SLC27A4	1.51e-05	272	138	10	GO:0016054
GeneOntologyBiologicalProcess	carboxylic acid catabolic process	GAD2 AMT FMO1 LONP2 CYP4F2 AKR1A1 ADIPOQ KYAT3 ALDH4A1 SLC27A4	1.51e-05	272	138	10	GO:0046395
GeneOntologyBiologicalProcess	carboxylic acid metabolic process	GAD2 DPYD SLC25A42 AMT FMO1 LONP2 ACLY CYP4F2 AKR1A1 IDH1 IDH2 IDH3A ADIPOQ UGT2A1 OSBPL6 ELOVL3 KYAT3 ALDH4A1 MFSD8 SLC27A4	1.85e-05	1035	138	20	GO:0019752
GeneOntologyBiologicalProcess	oxoacid metabolic process	GAD2 DPYD SLC25A42 AMT FMO1 LONP2 ACLY CYP4F2 AKR1A1 IDH1 IDH2 IDH3A ADIPOQ UGT2A1 OSBPL6 ELOVL3 KYAT3 ALDH4A1 MFSD8 SLC27A4	2.54e-05	1058	138	20	GO:0043436
GeneOntologyBiologicalProcess	organic acid metabolic process	GAD2 DPYD SLC25A42 AMT FMO1 LONP2 ACLY CYP4F2 AKR1A1 IDH1 IDH2 IDH3A ADIPOQ UGT2A1 OSBPL6 ELOVL3 KYAT3 ALDH4A1 MFSD8 SLC27A4	2.75e-05	1064	138	20	GO:0006082
GeneOntologyBiologicalProcess	glyoxylate cycle	IDH1 IDH2	4.44e-05	2	138	2	GO:0006097
GeneOntologyBiologicalProcess	tricarboxylic acid cycle	ACLY IDH1 IDH2 IDH3A	8.55e-05	35	138	4	GO:0006099
GeneOntologyBiologicalProcess	monocarboxylic acid metabolic process	GAD2 SLC25A42 FMO1 LONP2 ACLY CYP4F2 AKR1A1 IDH1 IDH2 ADIPOQ UGT2A1 OSBPL6 ELOVL3 MFSD8 SLC27A4	1.16e-04	731	138	15	GO:0032787
GeneOntologyBiologicalProcess	small molecule catabolic process	GAD2 DPYD AMT FMO1 LONP2 CYP4F2 AKR1A1 ADIPOQ KYAT3 ALDH4A1 SLC27A4	1.27e-04	421	138	11	GO:0044282
GeneOntologyBiologicalProcess	cardiac muscle thin filament assembly	NRAP NEB	1.33e-04	3	138	2	GO:0071691
Domain	Isocitrate/isopropylmalate_DH	IDH1 IDH2 IDH3A	3.34e-06	5	131	3	IPR001804
Domain	Iso_dh	IDH1 IDH2 IDH3A	3.34e-06	5	131	3	PF00180
Domain	IsoCit/isopropylmalate_DH_CS	IDH1 IDH2 IDH3A	3.34e-06	5	131	3	IPR019818
Domain	Iso_dh	IDH1 IDH2 IDH3A	3.34e-06	5	131	3	SM01329
Domain	IDH_IMDH	IDH1 IDH2 IDH3A	3.34e-06	5	131	3	PS00470
Domain	IsoPropMal-DH-like_dom	IDH1 IDH2 IDH3A	3.34e-06	5	131	3	IPR024084
Domain	-	IDH1 IDH2 IDH3A	3.34e-06	5	131	3	3.40.718.10
Domain	Isocitrate_DH_NADP	IDH1 IDH2	4.88e-05	2	131	2	IPR004790
Domain	CDC50/LEM3_fam	TMEM30B TMEM30A	4.88e-05	2	131	2	IPR005045
Domain	CDC50	TMEM30B TMEM30A	4.88e-05	2	131	2	PF03381
Domain	G_DYNAMIN_dom	EHD2 MFN2 SRL	1.16e-04	14	131	3	IPR030381
Domain	G_DYNAMIN_2	EHD2 MFN2 SRL	1.16e-04	14	131	3	PS51718
Domain	Dynamin_GTPase	EHD2 MFN2 SRL	1.44e-04	15	131	3	IPR001401
Domain	Dynamin_SF	EHD2 MFN2 SRL	1.44e-04	15	131	3	IPR022812
Domain	Dynamin_N	EHD2 MFN2 SRL	1.44e-04	15	131	3	PF00350
Domain	Na/H_exchanger_6	SLC9A9 SLC9A7	1.46e-04	3	131	2	IPR002090
Domain	Nebulin	NRAP NEB	2.90e-04	4	131	2	PF00880
Domain	NEBULIN	NRAP NEB	2.90e-04	4	131	2	PS51216
Domain	C5_MTASE_1	DNMT3A DNMT3B	2.90e-04	4	131	2	PS00094
Domain	C5_MTASE_2	DNMT3A DNMT3B	2.90e-04	4	131	2	PS00095
Domain	SAM_MT_C5	DNMT3A DNMT3B	2.90e-04	4	131	2	PS51679
Domain	DNA_methylase	DNMT3A DNMT3B	2.90e-04	4	131	2	PF00145
Domain	NEBU	NRAP NEB	2.90e-04	4	131	2	SM00227
Domain	ADD	DNMT3A DNMT3B	2.90e-04	4	131	2	IPR025766
Domain	Nebulin	NRAP NEB	2.90e-04	4	131	2	IPR013998
Domain	C5_MeTfrase	DNMT3A DNMT3B	2.90e-04	4	131	2	IPR001525
Domain	C5_DNA_meth_AS	DNMT3A DNMT3B	2.90e-04	4	131	2	IPR018117
Domain	Nebulin_repeat	NRAP NEB	2.90e-04	4	131	2	IPR000900
Domain	ADD	DNMT3A DNMT3B	2.90e-04	4	131	2	PS51533
Domain	EHD_N	EHD2 SRL	4.82e-04	5	131	2	IPR031692
Domain	EHD_N	EHD2 SRL	4.82e-04	5	131	2	PF16880
Domain	FAD/NAD-binding_dom	DPYD FMO1 PPOX OSGIN1	6.85e-04	57	131	4	IPR023753
Domain	Glyco_hydro_47	MAN1A1 MAN1A2	1.00e-03	7	131	2	PF01532
Domain	-	MAN1A1 MAN1A2	1.00e-03	7	131	2	1.50.10.50
Domain	Glyco_hydro_47	MAN1A1 MAN1A2	1.33e-03	8	131	2	IPR001382
Domain	NaH_exchanger	SLC9A9 SLC9A7	1.70e-03	9	131	2	IPR004709
Pathway	KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION	ACLY IDH1 IDH2 IDH3A	3.42e-07	9	104	4	M47937
Pathway	KEGG_CITRATE_CYCLE_TCA_CYCLE	ACLY IDH1 IDH2 IDH3A	7.55e-05	31	104	4	M3985
Pathway	WP_GLUTATHIONE_AND_ONECARBON_METABOLISM	AMT IDH1 DNMT3A DNMT3B	1.23e-04	35	104	4	MM15815
Pathway	KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS	MAN1A1 MAN1A2 MOGS	2.04e-04	16	104	3	M47632
Pathway	WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC	ACLY IDH1 IDH3A	2.04e-04	16	104	3	M39489
Pathway	REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	SLC13A2 RHAG SLC6A1 SLC6A7 SLC18A2	2.42e-04	76	104	5	MM15072
Pathway	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	SLC6A1 SLC6A7 SLC18A2	3.47e-04	19	104	3	M27362
Pathway	REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	SLC6A1 SLC6A7 SLC18A2	3.47e-04	19	104	3	MM15107
Pathway	BIOCARTA_ERAD_PATHWAY	MAN1A1 MAN1A2 MOGS	3.47e-04	19	104	3	M22013
Pathway	KEGG_N_GLYCAN_BIOSYNTHESIS	MAN1A1 MAN1A2 MOGS MGAT5B	3.60e-04	46	104	4	M11079
Pathway	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	SLC9A9 SLC13A2 RHAG SLC6A1 SLC6A7 SLC18A2 SLC9A7 SLC27A4	3.75e-04	238	104	8	MM15076
Pathway	REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	SLC13A2 RHAG SLC6A1 SLC6A7 SLC18A2	3.86e-04	84	104	5	M27334
Pathway	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	SLC9A9 SLC13A2 RHAG SLC6A1 SLC6A7 SLC18A2 SLC9A7 SLC27A4	5.07e-04	249	104	8	M5988
Pathway	REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI	MAN1A1 MAN1A2	5.31e-04	5	104	2	M27954
Pathway	REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI	MAN1A1 MAN1A2	5.31e-04	5	104	2	MM15670
Pathway	REACTOME_MTORC1_MEDIATED_SIGNALLING	SLC38A9 RRAGB EIF4G1	7.05e-04	24	104	3	M3492
Pathway	REACTOME_CA2_ACTIVATED_K_CHANNELS	KCNN4 KCNMB3	7.93e-04	6	104	2	MM14543
Pathway	REACTOME_MTORC1_MEDIATED_SIGNALLING	SLC38A9 RRAGB EIF4G1	7.97e-04	25	104	3	MM14650
Pathway	WP_NGLYCAN_BIOSYNTHESIS	MAN1A1 MAN1A2 MOGS MGAT5B	8.18e-04	57	104	4	M48051
Pubmed	DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.	IDH1 IDH2 DNMT3A	6.81e-08	3	143	3	24699305
Pubmed	Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.	IDH1 IDH2 DNMT3A	6.81e-08	3	143	3	26703962
Pubmed	Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma.	IDH1 IDH2 IDH3A	6.81e-08	3	143	3	34269949
Pubmed	Molecular evaluation of DNMT3A and IDH1/2 gene mutation: frequency, distribution pattern and associations with additional molecular markers in normal karyotype Indian acute myeloid leukemia patients.	IDH1 IDH2 DNMT3A	6.81e-08	3	143	3	24606448
Pubmed	Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.	IDH1 IDH2 DNMT3A	6.81e-08	3	143	3	28408400
Pubmed	Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer.	IDH1 IDH2 DNMT3A	2.71e-07	4	143	3	24887488
Pubmed	GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations.	IDH1 IDH2 DNMT3A	2.71e-07	4	143	3	23187294
Pubmed	Defining the membrane proteome of NK cells.	DPP4 MAN1A1 MYCBP2 LONP2 MED16 ACLY LEMD2 RECQL HUWE1 MAN1A2 MOGS HNRNPUL2 NBEAL2 HPS6 EIF4G1 MMGT1 TMEM30A CLINT1 SLC27A4	3.52e-07	1168	143	19	19946888
Pubmed	Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.	IDH1 IDH2 DNMT3A	6.77e-07	5	143	3	23365461
Pubmed	Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia.	IDH1 IDH2 DNMT3A	6.77e-07	5	143	3	23135354
Pubmed	Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.	MAN1A1 MAN1A2 MOGS MGAT5B	1.89e-06	22	143	4	8673525
Pubmed	Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation.	MAN1A1 MAN1A2 MOGS MGAT5B	1.89e-06	22	143	4	9109416
Pubmed	Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum.	MAN1A1 MAN1A2 MOGS MGAT5B	1.89e-06	22	143	4	11530211
Pubmed	Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.	MAN1A1 MAN1A2 MOGS MGAT5B	2.28e-06	23	143	4	8093218
Pubmed	Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins.	MAN1A1 MAN1A2 MOGS MGAT5B	2.28e-06	23	143	4	3099781
Pubmed	Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.	MAN1A1 MAN1A2 MOGS MGAT5B	2.28e-06	23	143	4	3264072
Pubmed	Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function.	MAN1A1 MAN1A2 MOGS MGAT5B	2.28e-06	23	143	4	1736542
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	DPP4 MAN1A1 ACLY TMEM59 ZG16B AKR1A1 IDH1 HUWE1 NEB SLC13A2 TF EHD2 CRYZ FCGBP MOGS MEGF8	4.78e-06	1016	143	16	19056867
Pubmed	Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.	SLC25A27 SLC25A42 AMT ACLY COQ8B IDH1 IDH2 IDH3A NCOA4 PPOX C1QBP MFN2 KYAT3 ALDH4A1 IQCE	6.91e-06	926	143	15	20877624
Pubmed	The human immunoglobulin kappa locus. Characterization of the duplicated A regions.	IGKV2D-30 IGKV2D-24 IGKV2-30	8.00e-06	10	143	3	1551402
Pubmed	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.	DPYD FMO1 FMO6P UGT2A1 ALDH4A1	8.00e-06	66	143	5	19898482
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	FKBP10 AMT ACLY IDH1 IDH2 IDH3A TF CRYZ MOGS C1QBP MMGT1 TMEM30A KYAT3 ALDH4A1	1.33e-05	859	143	14	31536960
Pubmed	Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.	MAN1A1 MAN1A2 MOGS MGAT5B	1.63e-05	37	143	4	2541446
Pubmed	Metabolism unhinged: IDH mutations in cancer.	IDH1 IDH2	1.68e-05	2	143	2	21383741
Pubmed	Distinct enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and Dnmt3b.	DNMT3A DNMT3B	1.68e-05	2	143	2	12869530
Pubmed	Local chromatin microenvironment determines DNMT activity: from DNA methyltransferase to DNA demethylase or DNA dehydroxymethylase.	DNMT3A DNMT3B	1.68e-05	2	143	2	26098813
Pubmed	IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?	IDH1 IDH2	1.68e-05	2	143	2	30176240
Pubmed	Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.	IDH1 IDH2	1.68e-05	2	143	2	34078652
Pubmed	IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.	IDH1 IDH2	1.68e-05	2	143	2	23894344
Pubmed	The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin.	DNMT3A DNMT3B	1.68e-05	2	143	2	15456878
Pubmed	High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.	IDH1 IDH2	1.68e-05	2	143	2	21480859
Pubmed	Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population.	IDH1 IDH2	1.68e-05	2	143	2	29874711
Pubmed	Liver-specific deletion of de novo DNA methyltransferases protects against glucose intolerance in high-fat diet-fed male mice.	DNMT3A DNMT3B	1.68e-05	2	143	2	38795327
Pubmed	Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA.	DNMT3A DNMT3B	1.68e-05	2	143	2	19620278
Pubmed	p32 regulates ER stress and lipid homeostasis by down-regulating GCS1 expression.	MOGS C1QBP	1.68e-05	2	143	2	29465311
Pubmed	Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.	IDH1 IDH2	1.68e-05	2	143	2	23391413
Pubmed	Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization.	DNMT3A DNMT3B	1.68e-05	2	143	2	15757890
Pubmed	Dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype.	DNMT3A DNMT3B	1.68e-05	2	143	2	33846253
Pubmed	Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.	IDH1 IDH2	1.68e-05	2	143	2	29126125
Pubmed	Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.	IDH1 IDH2	1.68e-05	2	143	2	20142433
Pubmed	IDH1 and IDH2 mutations in gliomas.	IDH1 IDH2	1.68e-05	2	143	2	23532369
Pubmed	[IDH1/2 mutations in gliomas].	IDH1 IDH2	1.68e-05	2	143	2	22147457
Pubmed	DNA methylation and demethylation in mammals.	DNMT3A DNMT3B	1.68e-05	2	143	2	21454628
Pubmed	Profound flanking sequence preference of Dnmt3a and Dnmt3b mammalian DNA methyltransferases shape the human epigenome.	DNMT3A DNMT3B	1.68e-05	2	143	2	15854647
Pubmed	The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.	IDH1 IDH2	1.68e-05	2	143	2	23015095
Pubmed	Absence of IDH mutation in colorectal cancers with microsatellite instability.	IDH1 IDH2	1.68e-05	2	143	2	26987944
Pubmed	Pyrosequencing of IDH1 and IDH2 mutations in brain tumors and non-neoplastic conditions.	IDH1 IDH2	1.68e-05	2	143	2	23111198
Pubmed	Insular primary glioblastomas with IDH mutations: Clinical and biological specificities.	IDH1 IDH2	1.68e-05	2	143	2	28116838
Pubmed	Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.	IDH1 IDH2	1.68e-05	2	143	2	20538800
Pubmed	IDH mutations in older patients with diffuse astrocytic gliomas.	IDH1 IDH2	1.68e-05	2	143	2	33137656
Pubmed	Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.	IDH1 IDH2	1.68e-05	2	143	2	25783747
Pubmed	DNA G-quadruplexes show strong interaction with DNA methyltransferases in vitro.	DNMT3A DNMT3B	1.68e-05	2	143	2	27468168
Pubmed	Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia.	IDH1 IDH2	1.68e-05	2	143	2	23039322
Pubmed	Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d-2-hydroxyglutarate oncometabolite level in dedifferentiated chondrosarcoma.	IDH1 IDH2	1.68e-05	2	143	2	31609487
Pubmed	Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.	IDH1 IDH2	1.68e-05	2	143	2	32027343
Pubmed	Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.	IDH1 IDH2	1.68e-05	2	143	2	23918605
Pubmed	MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.	DNMT3A DNMT3B	1.68e-05	2	143	2	17890317
Pubmed	IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management.	IDH1 IDH2	1.68e-05	2	143	2	31876581
Pubmed	IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.	IDH1 IDH2	1.68e-05	2	143	2	21997850
Pubmed	Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.	IDH1 IDH2	1.68e-05	2	143	2	22136423
Pubmed	Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning.	IDH1 IDH2	1.68e-05	2	143	2	32382048
Pubmed	Estimation of the occurrence rates of IDH1 and IDH2 mutations in gliomas and the reconsideration of IDH-wildtype anaplastic astrocytomas: an institutional experience.	IDH1 IDH2	1.68e-05	2	143	2	34162262
Pubmed	Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia.	IDH1 IDH2	1.68e-05	2	143	2	35351982
Pubmed	Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.	IDH1 IDH2	1.68e-05	2	143	2	28297679
Pubmed	Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target.	IDH1 IDH2	1.68e-05	2	143	2	22002076
Pubmed	Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group.	IDH1 IDH2	1.68e-05	2	143	2	22520341
Pubmed	[IDH1- and IDH2-mutations in brain glial tumors - the new antioncogenic mechanism].	IDH1 IDH2	1.68e-05	2	143	2	29863707
Pubmed	Acute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q).	IDH1 IDH2	1.68e-05	2	143	2	31685963
Pubmed	IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.	IDH1 IDH2	1.68e-05	2	143	2	21598255
Pubmed	Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer.	IDH1 IDH2	1.68e-05	2	143	2	31068457
Pubmed	The relationship between changes in serum myostatin and adiponectin levels in patients with obesity undergoing a weight loss program.	MSTN ADIPOQ	1.68e-05	2	143	2	34233657
Pubmed	A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.	IDH1 IDH2	1.68e-05	2	143	2	22922872
Pubmed	IDH Mutations in AML Patients; A higher Association with Intermediate Risk Cytogenetics.	IDH1 IDH2	1.68e-05	2	143	2	32212799
Pubmed	IDH mutations occur frequently in Chinese glioma patients and predict longer survival but not response to concomitant chemoradiotherapy in anaplastic gliomas.	IDH1 IDH2	1.68e-05	2	143	2	21874255
Pubmed	IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression.	IDH1 IDH2	1.68e-05	2	143	2	26228814
Pubmed	Co-deletion of chromosome 1p/19q and IDH1/2 mutation in glioma subsets of brain tumors in Chinese patients.	IDH1 IDH2	1.68e-05	2	143	2	22427879
Pubmed	Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production.	IDH1 IDH2	1.68e-05	2	143	2	21996744
Pubmed	IDH mutation analysis in gliomas as a diagnostic and prognostic biomarker.	IDH1 IDH2	1.68e-05	2	143	2	23451940
Pubmed	Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma.	IDH1 IDH2	1.68e-05	2	143	2	38842680
Pubmed	A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders.	IDH1 IDH2	1.68e-05	2	143	2	20962861
Pubmed	Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.	IDH1 IDH2	1.68e-05	2	143	2	28552826
Pubmed	The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo.	IDH1 IDH2	1.68e-05	2	143	2	26046462
Pubmed	The influence of DNMT3A and DNMT3B gene polymorphisms on acute myeloid leukemia risk in a Moroccan population.	DNMT3A DNMT3B	1.68e-05	2	143	2	32912818
Pubmed	Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome.	DNMT3A DNMT3B	1.68e-05	2	143	2	16501171
Pubmed	Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors.	IDH1 IDH2	1.68e-05	2	143	2	23232569
Pubmed	Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia.	IDH1 IDH2	1.68e-05	2	143	2	23641016
Pubmed	Distinct IDH1/IDH2 mutation profiles in purely insular versus paralimbic WHO Grade II gliomas.	IDH1 IDH2	1.68e-05	2	143	2	23330999
Pubmed	IDH1/2 Mutations in Sinonasal Undifferentiated Carcinomas : Previously Undescribed IDH2 R172K and R140x Variants.	IDH1 IDH2	1.68e-05	2	143	2	35486703
Pubmed	Metabolism of glioma and IDH1/IDH2 mutations.	IDH1 IDH2	1.68e-05	2	143	2	21885076
Pubmed	IDH1/2 Mutations in Cancer Stem Cells and Their Implications for Differentiation Therapy.	IDH1 IDH2	1.68e-05	2	143	2	34967233
Pubmed	Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status.	IDH1 IDH2	1.68e-05	2	143	2	22790483
Pubmed	IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution.	IDH1 IDH2	1.68e-05	2	143	2	32333643
Pubmed	IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis.	IDH1 IDH2	1.68e-05	2	143	2	32948843
Pubmed	Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulation.	IDH1 IDH2	1.68e-05	2	143	2	27431380
Pubmed	Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.	DNMT3A DNMT3B	1.68e-05	2	143	2	25639876
Pubmed	Functional evaluation of isocitrate dehydrogenase 1 and 2 variants of unclear significance in chronic myeloid neoplasms.	IDH1 IDH2	1.68e-05	2	143	2	31706195
Pubmed	Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia.	IDH1 IDH2	1.68e-05	2	143	2	34946913
Pubmed	Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma.	IDH1 IDH2	1.68e-05	2	143	2	24569570
Pubmed	Isocitrate dehydrogenase 1/2 mutational analyses and 2-hydroxyglutarate measurements in Wilms tumors.	IDH1 IDH2	1.68e-05	2	143	2	21225914
Pubmed	Cancer-associated IDH mutations: biomarker and therapeutic opportunities.	IDH1 IDH2	1.68e-05	2	143	2	20972461
Cytoband	10q24.32	HPS6 ELOVL3 MFSD13A	5.83e-05	24	144	3	10q24.32
GeneFamily	Solute carriers	SLC25A27 SLC9A9 SLC25A42 SLC38A9 SLC12A8 SLC13A2 RHAG SLC6A1 SLC6A7 SLC39A12 SLC18A2 SLC9A7 SLC27A4	2.81e-08	395	83	13	752
GeneFamily	Mannosidases alpha class 1	MAN1A1 MAN1A2	1.24e-04	4	83	2	1193
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV2D-30 IGKV2D-24 IGKV2-30 IGKV2-24	5.76e-04	83	83	4	351
GeneFamily	Immunoglobulin like domain containing	TMIGD2 IGSF5 SLAMF1 HMCN2 KIRREL1	1.95e-03	193	83	5	594
GeneFamily	Kallikreins	KLK14 KLK4	2.40e-03	16	83	2	616
ToppCell	proximal-Epithelial-Serous-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRAP ZG16B CCDC175 CHST1 SLC13A2 TF FCGBP KCNN4	2.45e-07	195	144	8	06b73abc1f32543f2a51db52dc6424a2a398fe0f
ToppCell	proximal-Epithelial-Serous\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRAP ZG16B CCDC175 CHST1 SLC13A2 TF FCGBP KCNN4	2.45e-07	195	144	8	cb62f04f0e45bfb36eed2e7a3fc54d6d390b2ed1
ToppCell	proximal-3-Epithelial-Serous\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NRAP ZG16B CCDC175 CHST1 SLC13A2 TF FCGBP KCNN4	2.45e-07	195	144	8	24a6a566143b04e37ad002e4c55037a0460ac2ef
ToppCell	facs-GAT-Fat-18m-Epithelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAL3ST1 IGSF5 SLC13A2 TMEM171 FCGBP PRAP1 MS4A8	1.28e-06	168	144	7	d6c8056b7d6b937bb91e6b33beeb1075dce1685c
ToppCell	facs-GAT-Fat-18m-Epithelial-epithelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAL3ST1 IGSF5 SLC13A2 TMEM171 FCGBP PRAP1 MS4A8	1.28e-06	168	144	7	7102c52bf1b2ba67bb3700932181a2e0a6627711
ToppCell	facs-GAT-Fat-18m-Epithelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAL3ST1 IGSF5 SLC13A2 TMEM171 FCGBP PRAP1 MS4A8	1.28e-06	168	144	7	68a2f9fd53b54023241acd1620cf24226f639c1b
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TMEM30B GAD2 MAN1A1 RASSF10 LFNG TMEM171 MS4A8	1.81e-06	177	144	7	43dce527392f3b8364bb6a55268ce9d6518d3a29
ToppCell	facs-Heart-RA-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN1A1 MYCBP2 HNRNPUL1 MOGS HNRNPUL2 EIF4G1 CLINT1	1.88e-06	178	144	7	b505e2550860e777535ee95f29c936242fd607f1
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP PRAP1 KCNN4	2.18e-06	182	144	7	2f7d9c0bf7155ac376e63fc9d9542b5c3ab89f04
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP PRAP1 KCNN4	2.18e-06	182	144	7	9b556e44ed6aaa50ec572224f5751fb02ce63438
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP PRAP1 KCNN4	2.34e-06	184	144	7	00db9eaaffe9c598222e14b2f9638cbcce1602d7
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)-SMG_serous_(nasal)_L.0.6.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP PRAP1 KCNN4	2.79e-06	189	144	7	29423dc66a8af71293b2e1670acc6c34dfe63608
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP PRAP1 KCNN4	2.89e-06	190	144	7	e3a07dcffb75375693738bef1668353f4cdba5d7
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)-SMG_serous_(nasal)_L.0.6.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP PRAP1 KCNN4	2.89e-06	190	144	7	70b14b649ae893513e6d61b7288d6f6df97f09d9
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP PRAP1 KCNN4	2.89e-06	190	144	7	f6f8451eef5a387b0a1fd2e90ab965928ea2ea82
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 TF RHAG FCGBP KCNN4	2.99e-06	191	144	7	13460059a0c1ed9f476cef28b8ad4c06349056c6
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NRAP ZG16B SLC13A2 TF FCGBP PRAP1 KCNN4	3.32e-06	194	144	7	e90f6717e3421f8978d1fc1b2f30dcf69f6fcce7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FMO1 CYP4F2 AKR1A1 IDH1 SLC13A2 PRAP1 ALDH4A1	3.67e-06	197	144	7	9b038dac4d4d306aa40ec07d79374c4fe9c604a6
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Mucous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NRAP ZG16B SLC12A8 TF FCGBP HNRNPUL2 KCNMB3	3.80e-06	198	144	7	2ae9564da9913510141994262f3739eb095e0a68
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPP4 FMO1 AKR1A1 IDH1 SLC13A2 PRAP1 ALDH4A1	3.92e-06	199	144	7	4bde35e5df019189433d65d415e29a0c1145ac66
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NRAP CHST1 SLC6A1 SLC39A12 MROH7 ALDH4A1 GPC5	4.06e-06	200	144	7	7a8160e6477708f22e48c609bf8f43f3715dcb03
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ZG16B RASSF10 TF FCGBP PRAP1 KCNN4	1.27e-05	158	144	6	adad97e6cf479d42791c5ba9cbc5f15f469322bf
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PAPOLB MFSD6L TMEM171 KCNN4 OSGIN1	1.30e-05	93	144	5	38a075f06001a2fd1ec77fc301a08a87618a2440
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PAPOLB MFSD6L TMEM171 KCNN4 OSGIN1	1.30e-05	93	144	5	a0117b12889d9c48294a7ccea4284d00c087889f
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PAPOLB MFSD6L TMEM171 KCNN4 OSGIN1	1.30e-05	93	144	5	b3e057132633b25bd4f8ff2c0aa203ade0f3ba4c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 PCARE ARHGAP6 KLK4 KIRREL1 GPC5	1.93e-05	170	144	6	40675b55269ffa57fb7fcdb903c81b02b4e01f8f
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DPP4 MFSD6L TMEM171 KCNN4 OSGIN1	2.03e-05	102	144	5	2c3622fc3cd62d9b7e185d0204cf7f03e7dde73c
ToppCell	droplet-Limb_Muscle-nan-24m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAL3ST1 RASSF10 SLAMF1 MAP3K4 DNAH17 DNMT3B	2.50e-05	178	144	6	f2002a5c4758d0af6c1880ca12f0af0d5e8888e4
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP KCNN4	2.58e-05	179	144	6	ec331b1132f965581f851a3b29e62873c4140e6c
ToppCell	Ciliated_cells-A-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	LKAAEAR1 ZG16B KATNAL1 OSBPL6 CFAP44 SLC27A4	2.58e-05	179	144	6	1c41314b6fcfcac8d62034e7037570120d58f20f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPYD MAN1A1 TCERG1L CCDC175 SLC6A7 MGAT5B	2.83e-05	182	144	6	14a117c5e50db31ee1b2cf4df4d133451fd6d55f
ToppCell	droplet-Heart-nan-18m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAL3ST1 IGSF5 ADIPOQ KCNN4 ELOVL3 CFAP44	2.92e-05	183	144	6	1701c8c212f1fdb6e4764375542a203e19753d14
ToppCell	cellseq-Epithelial-Epithelial_Glandular-Serous\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	3.01e-05	184	144	6	f0cbb5b76e092be4188a9804ef5cf7a83cd7644f
ToppCell	cellseq-Epithelial-Epithelial_Glandular-Serous-Serous\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	3.01e-05	184	144	6	5433ba7bbab553ff668619822d1a9208e15cd59f
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 FCGBP PRAP1 KCNN4	3.10e-05	185	144	6	c4ca213a59ffab183a7719c2b4bc3f658a95002d
ToppCell	droplet-Heart-nan-18m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAL3ST1 IGSF5 ADIPOQ KCNN4 ELOVL3 CFAP44	3.10e-05	185	144	6	c61267cfadea018794f7964904445787629a40d1
ToppCell	droplet-Heart-nan-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAL3ST1 IGSF5 ADIPOQ KCNN4 ELOVL3 CFAP44	3.10e-05	185	144	6	3a592719d5643011954f89d5bb61a5e94682b68e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 SLC9A9 PCARE SLC6A1 ARHGAP6 SRL	3.20e-05	186	144	6	948815663c212c4311329d503b5991cbbbff9808
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST1 LCAT LFNG SLC6A1 SLC39A12 GPC5	3.20e-05	186	144	6	ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM30B FMO1 IDH1 IDH3A C1QBP KCNN4	3.20e-05	186	144	6	af038994a6c32261f426b0c40c39be4a9099fe43
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-SMG_serous_secreting_cell-SMG_serous_(nasal)-SMG_serous_(nasal)_L.0.6.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF RHAG KCNN4	3.40e-05	188	144	6	02b3aae071ff1f469d52a4d513a4eb46ae70bba3
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 SLC9A9 PCARE SLC6A1 ARHGAP6 SRL	3.40e-05	188	144	6	72cbfe9dc0583dbeafa6cb0945fa370d0c808284
ToppCell	3'-Airway_Nasal_SMG-Epithelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP KCNN4	3.50e-05	189	144	6	a174f5757a53a68a753111a204efc1bb6da80d8b
ToppCell	3'-Airway_Nasal_SMG\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP KCNN4	3.50e-05	189	144	6	bb2b626645e9f060f0d99d05d1ea651fd8bc4945
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B SLC13A2 TF FCGBP KCNN4	3.50e-05	189	144	6	24741fe93438c1031fc5caa8837ef82d8d23f099
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM30B FMO1 IDH1 IDH3A C1QBP KCNN4	3.60e-05	190	144	6	a124e1c12af70161b9ead5d677afa660610444ee
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHST1 LCAT LFNG SLC6A1 SLC39A12 GPC5	3.71e-05	191	144	6	fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM30B DPP4 ACLY IDH3A C1QBP KCNN4	3.71e-05	191	144	6	7411b253b16e4d472be0925dee49188f0fd6b0b5
ToppCell	facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 IDH2 NCOA4 MOGS KCNN4 DNMT3B	3.82e-05	192	144	6	03dcd9405d3d76fc7455066ba5d83c09cd17072d
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	3.82e-05	192	144	6	48b69d6f46e583378186d2993a202f9584688bfa
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	3.93e-05	193	144	6	56145861ef5e7655db9ad0d11b82f72dcadf285d
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	3.93e-05	193	144	6	3d1710a6060d3a70994a206334ccb16cd63e5f20
ToppCell	facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRG3 IDH2 MOGS KCNN4 MFSD13A DNMT3B	4.05e-05	194	144	6	c9ebdcc2ea600975dade68a41fa65d1f8a5a5926
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 TMEM59 AKR1A1 IDH1 UGT2A1 MS4A8	4.05e-05	194	144	6	40251e6415a62fa55d86f2e8609bf0402e1c1abb
ToppCell	3'-Broncho-tracheal_SMG-Epithelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	4.05e-05	194	144	6	f1d057c4bf57e75ad5a821e5f3de335dbff69062
ToppCell	3'-Broncho-tracheal_SMG\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	4.05e-05	194	144	6	42558822d7e260e7d8cf2539f1f7426e5774edfb
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	4.05e-05	194	144	6	0d97dee07846416c77a861994912a9207f29ceb3
ToppCell	cellseq-Epithelial-Epithelial_Glandular\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZG16B SLC13A2 TF FCGBP UGT2A1 KCNN4	4.05e-05	194	144	6	d0fb1ff5cf0738881e114a58f0b27489f781d72b
ToppCell	3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_tracheobronchial_serous_cell-SMG_serous_(bronchial)-SMG_serous_(bronchial)_L.0.6.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	4.05e-05	194	144	6	a8238f312a973cadf6eb29c1e02ba898c0a20412
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 TMEM59 ZG16B FCGBP UGT2A1 MS4A8	4.16e-05	195	144	6	576142b4e75457c0973051bccc4163bd624496af
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DPP4 TMEM59 ZG16B FCGBP UGT2A1 MS4A8	4.16e-05	195	144	6	8f151066ad3ebd9661ea0b733f03c2ce1518f9ad
ToppCell	Striatum-Macroglia-ASTROCYTE-Gja1\|Striatum / BrainAtlas - Mouse McCarroll V32	FMO1 LCAT SLC39A12 MROH7 GPC5	4.27e-05	119	144	5	d47880ef1cff036192c43646a04fa8598dd7e1f4
ToppCell	Striatum-Macroglia-ASTROCYTE\|Striatum / BrainAtlas - Mouse McCarroll V32	FMO1 LCAT SLC39A12 MROH7 GPC5	4.27e-05	119	144	5	0583387cc4497cf991fa42a81f2f66d9c6b774eb
ToppCell	cellseq2\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZG16B CHST1 SLC13A2 TF FCGBP KCNN4	4.28e-05	196	144	6	d9e1b8386817a668eca90288b6d0e20be4138bf8
ToppCell	Bronchial_Biopsy-Epithelial-Club\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	DPP4 ZG16B IDH1 SLC13A2 FCGBP UGT2A1	4.28e-05	196	144	6	057d150bdf0cad959fd03ec2d1560a96ba03fae9
ToppCell	Bronchial_Biopsy-Epithelial-Club\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DPP4 ZG16B IDH1 SLC13A2 FCGBP UGT2A1	4.41e-05	197	144	6	3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPP4 FMO1 AKR1A1 IDH1 PRAP1 ALDH4A1	4.53e-05	198	144	6	a9d72b17adfddb6ac1857c5f094280e86582693b
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL4A6 KLK14 TF SLC6A1 PLEKHH1 UGT2A1	4.53e-05	198	144	6	de5987588b9fa9ee8c595ba06d7d844ead0e3c74
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DPP4 FMO1 AKR1A1 IDH1 PRAP1 ALDH4A1	4.53e-05	198	144	6	b933bd66f544822fcf1f2aa2d928c31500e2b3f4
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	GAD2 EHD2 SLC6A1 NBEAL2 DNMT3A	4.62e-05	121	144	5	b2d571f571133c281d72584fe925cebbd2317829
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZG16B CDC20B SLC13A2 TF FCGBP UGT2A1	4.66e-05	199	144	6	3c3133d0aa65338a576634def13e7f0f5c573a10
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZG16B KLK14 SLC13A2 TF FCGBP UGT2A1	4.66e-05	199	144	6	a706ad5cd5e0dc8d7e925a05e45b07d35963f294
ToppCell	Biopsy_Control_(H.)-Epithelial-MUC5AC+_High\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ZG16B IGSF5 MFSD6L SLC13A2 FCGBP UGT2A1	4.66e-05	199	144	6	a5240868cea40574ed4ee45eb27a00c1812957ed
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FMO1 CYP4F2 AKR1A1 SLC13A2 PRAP1 ALDH4A1	4.79e-05	200	144	6	825aad08431dd6b54aa636ace6efc821dfaf8014
ToppCell	Serous\|World / shred by cell class for turbinate	ZG16B SLC13A2 FCGBP PRAP1 KCNN4	1.28e-04	150	144	5	6a326662d58b0f17d6efa8cc28571f4cbbf57c2d
ToppCell	PND07-28-samps-Myeloid-Macrophage-macrophage-C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	KLK14 PIWIL2 MROH7 PAX4	1.32e-04	80	144	4	3413ac5e1c1e59eab6a83b889b870a8db4efccb9
ToppCell	droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l14\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADGRG3 GAL3ST1 COQ8B PIWIL2 SLC18A2	1.36e-04	152	144	5	0fda8980b10ce16179dea92301db74d728f41794
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TMIGD2 ZG16B MS4A8 OSGIN1 DNMT3B	1.36e-04	152	144	5	595afcfa8b161e291fcaf2afc7336bac9b6fae0f
ToppCell	18-Airway-Epithelial-Goblet-like_secretory\|Airway / Age, Tissue, Lineage and Cell class	ZG16B PLPP7 MFSD6L TF FCGBP	1.40e-04	153	144	5	14a60220e169ce642771636de982a7b02e5b2608
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM30B MFSD6L CYP4F2 IDH2 DMAC1	1.44e-04	154	144	5	dcbc6705e91ec744801b621e5d0733a78a7a90ca
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZG16B SLAMF1 LFNG HNRNPUL2 DMAC1	1.49e-04	155	144	5	a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC25A42 AMT KATNAL1 ADIPOQ MROH7	1.73e-04	160	144	5	8374ae912337947b2cc8d17d5840f306361fe1ff
ToppCell	Club-club-13\|World / Class top	FMO1 AKR1A1 IDH1 IDH2 SLC9A7	1.83e-04	162	144	5	7d18f05a65ac715e62d610df9cc4a26539340dee
ToppCell	PND07-28-samps-Epithelial-Epithelial-non_alveolar-Club_cell\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	AMT MOGS HPS6 UGT2A1 OSGIN1	1.83e-04	162	144	5	aed15eef32419b8a4e2afdb9776c2bf2802e96f1
ToppCell	TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-2\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	ZG16B SLC13A2 MSTN FMO6P ADIPOQ	1.88e-04	163	144	5	2dfd11f5803822ba01b92adf4395a3b3adda68f5
ToppCell	facs-Heart-RA-18m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF5 SLC13A2 TMEM171 PRAP1 MS4A8	1.88e-04	163	144	5	13557be854878abc1bcdab909b49b8292d064145
ToppCell	facs-Heart-RA-18m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF5 SLC13A2 TMEM171 PRAP1 MS4A8	1.88e-04	163	144	5	6c1d1646410e785886d2de103b4b12f73e91edff
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD2 FMO1 SLC6A1 ARHGAP6 KIRREL1	1.88e-04	163	144	5	bba830a302919c8b33f914a8839877fc21dd28a0
ToppCell	11.5-Airway-RBC-RBC\|Airway / Age, Tissue, Lineage and Cell class	ADGRG3 TF RHAG SLC18A2 KCNN4	1.99e-04	165	144	5	8618b2c5659aa70c7c9d6e51a227ac612b4ad17b
ToppCell	11.5-Airway-RBC\|Airway / Age, Tissue, Lineage and Cell class	ADGRG3 TF RHAG SLC18A2 KCNN4	1.99e-04	165	144	5	46042340a373adaf1c439b2301e02fbae3e31a4f
ToppCell	Club-club-2\|World / Class top	FMO1 IDH2 SLC13A2 FCGBP OSGIN1	2.05e-04	166	144	5	56f11efb6b686b3ee2c34a051f626e3d761b5112
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TMEM59 ZG16B TF FCGBP UGT2A1	2.11e-04	167	144	5	31633899aae852873a4887e72c621474b0a51a33
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GAD2 NEB SLAMF1 KCNN4 SOHLH1	2.16e-04	168	144	5	2d2eab3190374f79f373e31c8b062ff4e1766396
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GAD2 NEB SLAMF1 KCNN4 SOHLH1	2.16e-04	168	144	5	df58156721457b34af1e81c0eb8a7243cbbfb303
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A6 NRAP RNF112 RRAGB SRL	2.23e-04	169	144	5	88aa2246ede582c2e11de63228d76f520889ecb3
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4\|TCGA-Liver / Sample_Type by Project: Shred V9	GAL3ST1 SLC13A2 ZNF850 DNMT3A DNMT3B	2.23e-04	169	144	5	0a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B0\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	DPP4 IGHV1-69-2 SLAMF1 ARHGAP6 OSBPL6	2.23e-04	169	144	5	89b5452e0d8d058648a1d2659f1611fd6aebc6b6
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A6 NRAP RNF112 RRAGB SRL	2.23e-04	169	144	5	a6a5b00912b653fad2ca7f096deaf35c9ef85e5b
ToppCell	facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC25A42 IDH1 NEB MFN2 MS4A8	2.23e-04	169	144	5	813472d429c0b12580b17b440e00a6d8beb7947f
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A6 NRAP RNF112 RRAGB SRL	2.23e-04	169	144	5	42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f
Computational	Organic acid metabolism.	GAD2 AMT CYP4F2 IDH1 IDH2 ALDH4A1	2.17e-05	82	75	6	MODULE_40
Computational	Genes in the cancer module 286	IDH1 IDH2 IDH3A CRYZ	1.21e-04	37	75	4	MODULE_286
Computational	Oxidoreductases.	AKR1A1 IDH1 IDH2	1.40e-04	15	75	3	MODULE_519
Drug	AC1NRATE	DPP4 MAN1A1 GAL3ST1 SLC6A1 MAN1A2 MOGS SLC18A2	7.29e-07	83	138	7	CID005288086
Drug	C015407	IDH1 IDH2 IDH3A TF	8.85e-07	13	138	4	CID003014226
Drug	3-amino-2-oxopropyl phosphate	IDH1 IDH2 IDH3A	2.16e-06	5	138	3	CID000000005
Drug	3-ethylmalate	IDH1 IDH2 IDH3A	2.16e-06	5	138	3	CID000439619
Drug	BDTD	IDH1 IDH2 IDH3A	2.16e-06	5	138	3	CID003036435
Drug	adenosine 5'-(2-bromoethyl)-phosphate	IDH1 IDH2 IDH3A	2.16e-06	5	138	3	CID000194660
Drug	bromoketoglutarate	IDH1 IDH2 IDH3A	4.30e-06	6	138	3	CID000195934
Drug	bumetanide	DPYD SLC9A9 KLK14 SLC12A8 SLC13A2 SLC6A1 KLK4 SLC9A7 KCNN4	5.37e-06	209	138	9	CID000002471
Drug	Metazamide	IDH1 IDH2 IDH3A	7.49e-06	7	138	3	CID000026433
Drug	8-BDB-TNAD	IDH1 IDH2 IDH3A	7.49e-06	7	138	3	CID000170328
Drug	citrazinic acid	IDH1 IDH2 IDH3A	1.19e-05	8	138	3	CID000007425
Drug	Asparagusate	IDH1 IDH2 IDH3A	1.78e-05	9	138	3	CID000016682
Drug	AC1N02M5	IDH1 IDH2 IDH3A	1.78e-05	9	138	3	CID003956233
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; PC3; HT_HG-U133A	COL4A6 IDH2 CEP68 ARHGAP6 HNRNPUL2 ALDH4A1 CFAP44 IQCE	2.57e-05	195	138	8	5078_DN
Drug	Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	DPP4 APBB1 WDR91 RAB28 KIRREL1 ALDH4A1 MFSD13A DNMT3B	2.57e-05	195	138	8	2121_UP
Drug	Pindolol [13523-86-9]; Up 200; 16.2uM; PC3; HT_HG-U133A	FKBP10 DPP4 LONP2 MED16 ARHGAP6 RAB28 MFN2 ALDH4A1	2.77e-05	197	138	8	2075_UP
Drug	beta-NADP	DPYD AMT FMO1 ACLY CYP4F2 AKR1A1 IDH1 IDH2 IDH3A FMO6P CRYZ ALDH4A1	4.53e-05	490	138	12	CID000000929
Drug	2-isopropylmalate	IDH1 IDH2 IDH3A	4.61e-05	12	138	3	CID000000036
Drug	1,3-butanedione	IDH1 IDH2 IDH3A	4.61e-05	12	138	3	CID000022747
Drug	homoisocitric acid	IDH1 IDH2 IDH3A	4.61e-05	12	138	3	CID005119182
Drug	AC1L19KJ	IDH1 IDH2 IDH3A	4.61e-05	12	138	3	CID000000589
Drug	hydride	GAD2 DPYD SLC9A9 AMT FMO1 CYP4F2 AKR1A1 IDH1 IDH2 IDH3A SLC13A2 PPOX CRYZ SLC18A2 SLC9A7 ALDH4A1	4.78e-05	835	138	16	CID000000783
Drug	magnesium citrate	IDH1 IDH2 IDH3A	7.55e-05	14	138	3	CID000008949
Drug	alpha-methylisocitrate	IDH1 IDH2 IDH3A	7.55e-05	14	138	3	CID000000513
Disease	hepatocellular clear cell carcinoma (is_implicated_in)	IDH1 IDH2	2.05e-05	2	134	2	DOID:5016 (is_implicated_in)
Disease	Chondroma	IDH1 IDH2	2.05e-05	2	134	2	C0936248
Disease	Enchondroma	IDH1 IDH2	2.05e-05	2	134	2	C1704356
Disease	endometriosis of uterus (is_marker_for)	DNMT3A DNMT3B	6.12e-05	3	134	2	DOID:288 (is_marker_for)
Disease	Maffucci Syndrome	IDH1 IDH2	6.12e-05	3	134	2	C0024454
Disease	Enchondromatosis	IDH1 IDH2	1.22e-04	4	134	2	C0014084
Disease	Hemangioma, Intramuscular	IDH1 IDH2	1.22e-04	4	134	2	C0205789
Disease	Histiocytoid hemangioma	IDH1 IDH2	1.22e-04	4	134	2	C0205788
Disease	Chorioangioma	IDH1 IDH2	1.22e-04	4	134	2	C0677608
Disease	Angioma	IDH1 IDH2	1.22e-04	4	134	2	C1959588
Disease	Angioimmunoblastic Lymphadenopathy	IDH2 DNMT3A	1.22e-04	4	134	2	C0020981
Disease	Hemangioma	IDH1 IDH2	1.22e-04	4	134	2	C0018916
Disease	congenital heart disease (biomarker_via_orthology)	DNMT3A DNMT3B	1.22e-04	4	134	2	DOID:1682 (biomarker_via_orthology)
Disease	Biliary Tract Neoplasm	IDH1 IDH2	3.03e-04	6	134	2	C0005426
Disease	Childhood Oligodendroglioma	IDH1 IDH2	4.24e-04	7	134	2	C0280475
Disease	Adult Oligodendroglioma	IDH1 IDH2	4.24e-04	7	134	2	C0279070
Disease	Oligodendroblastoma	IDH1 IDH2	4.24e-04	7	134	2	C0344461
Disease	Mixed Oligodendroglioma-Astrocytoma	IDH1 IDH2	4.24e-04	7	134	2	C0280793
Disease	Mixed Oligodendroglioma-Ependymoma	IDH1 IDH2	4.24e-04	7	134	2	C0751395
Disease	Well Differentiated Oligodendroglioma	IDH1 IDH2	4.24e-04	7	134	2	C0751396
Disease	fatty liver disease (biomarker_via_orthology)	ADIPOQ MFN2 SLC27A4	4.52e-04	33	134	3	DOID:9452 (biomarker_via_orthology)
Disease	oligodendroglioma	IDH1 IDH2	5.63e-04	8	134	2	C0028945
Disease	response to vitamin	CYP4F2 SLC6A1	5.63e-04	8	134	2	GO_0033273
Disease	Anaplastic Oligodendroglioma	IDH1 IDH2	5.63e-04	8	134	2	C0334590
Disease	Growth Disorders	RNF135 IDH2 DNMT3A	5.86e-04	36	134	3	C0018273
Disease	acute myeloid leukemia (is_implicated_in)	IDH1 IDH2 DNMT3A DNMT3B	5.92e-04	84	134	4	DOID:9119 (is_implicated_in)
Disease	Neoplasm Recurrence, Local	IDH1 IDH2 DNMT3A	7.43e-04	39	134	3	C0027643
Disease	Peripheral T-Cell Lymphoma	IDH2 DNMT3A	8.99e-04	10	134	2	C0079774
Disease	Generalized seizures	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0234533
Disease	Clonic Seizures	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0234535
Disease	Convulsive Seizures	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0751494
Disease	Seizures, Sensory	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0751496
Disease	Non-epileptic convulsion	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0751056
Disease	Atonic Absence Seizures	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0751123
Disease	Complex partial seizures	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0149958
Disease	Single Seizure	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0751110
Disease	Nonepileptic Seizures	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C3495874
Disease	Visual seizure	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0270824
Disease	Epileptic drop attack	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0270846
Disease	Vertiginous seizure	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0422855
Disease	Gustatory seizure	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0422854
Disease	Seizures, Somatosensory	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0422850
Disease	Olfactory seizure	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0422853
Disease	Seizures, Auditory	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0422852
Disease	Generalized Absence Seizures	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C4505436
Disease	Jacksonian Seizure	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C0022333
Disease	obesity (is_marker_for)	ADIPOQ MFN2 PRL SLC27A4	1.18e-03	101	134	4	DOID:9970 (is_marker_for)
Disease	Epileptic Seizures	GAD2 IDH2 SLC6A1 MIB1	1.18e-03	101	134	4	C4317109
Disease	Acute Promyelocytic Leukemia	IDH1 IDH2 DNMT3A	1.21e-03	46	134	3	C0023487
Disease	Absence Seizures	GAD2 IDH2 SLC6A1 MIB1	1.23e-03	102	134	4	C4316903
Disease	Convulsions	GAD2 IDH2 SLC6A1 MIB1	1.23e-03	102	134	4	C4048158
Disease	Tonic Seizures	GAD2 IDH2 SLC6A1 MIB1	1.23e-03	102	134	4	C0270844
Disease	prostatitis (biomarker_via_orthology)	DNMT3A DNMT3B	1.31e-03	12	134	2	DOID:14654 (biomarker_via_orthology)
Disease	polycystic ovary syndrome (is_marker_for)	NCOA4 ADIPOQ	1.31e-03	12	134	2	DOID:11612 (is_marker_for)
Disease	Hematologic Neoplasms	IDH1 IDH2	1.31e-03	12	134	2	C0376545
Disease	Seizures, Focal	GAD2 IDH2 SLC6A1 MIB1	1.32e-03	104	134	4	C0751495
Disease	Myoclonic Seizures	GAD2 IDH2 SLC6A1 MIB1	1.32e-03	104	134	4	C4317123
Disease	Tonic - clonic seizures	GAD2 IDH2 SLC6A1 MIB1	1.32e-03	104	134	4	C0494475
Disease	autoimmune thrombocytopenic purpura (is_marker_for)	DNMT3A DNMT3B	1.55e-03	13	134	2	DOID:8924 (is_marker_for)
Disease	Congestive heart failure	ACLY MSTN ADIPOQ PRL	1.62e-03	110	134	4	C0018802
Disease	Heart failure	ACLY MSTN ADIPOQ PRL	1.62e-03	110	134	4	C0018801
Disease	Left-Sided Heart Failure	ACLY MSTN ADIPOQ PRL	1.62e-03	110	134	4	C0023212
Disease	Heart Failure, Right-Sided	ACLY MSTN ADIPOQ PRL	1.62e-03	110	134	4	C0235527
Disease	Heart Decompensation	ACLY MSTN ADIPOQ PRL	1.62e-03	110	134	4	C1961112
Disease	Myocardial Failure	ACLY MSTN ADIPOQ PRL	1.62e-03	110	134	4	C1959583
Disease	early cardiac repolarization measurement	MYCBP2 MGAT5B	1.80e-03	14	134	2	EFO_0004885
Disease	nicotine dependence symptom count	DPYD MYCBP2 SLC38A9 EYA3 TF MGAT5B	1.97e-03	285	134	6	EFO_0009262
Disease	Dyschondroplasias	IDH1 IDH2	3.33e-03	19	134	2	C0013366
Disease	estrogen-receptor negative breast cancer	CASTOR2 C19orf12 KCNN4	4.18e-03	71	134	3	EFO_1000650
Disease	type 1 diabetes mellitus (is_marker_for)	ADIPOQ SLC18A2 DNMT3B	4.35e-03	72	134	3	DOID:9744 (is_marker_for)
Disease	fat intake measurement	NRAP DNMT3A	4.46e-03	22	134	2	EFO_0010809

Protein segments in the cluster

Peptide	Gene	Start	Entry
GIATWGIVVMADPKG	DMAC1	96	Q96GE9
PMSNLWLKGDKGSQG	COL4A6	961	Q14031
LLGAWMTSGQFKPVP	C19orf12	71	Q9NSK7
QTLAMGIVIDWAPKG	ERVK13-1	81	Q9NX77
TLPKMSGGWELELNG	C1QBP	101	Q07021
RVPQKQGGMGLASWS	CEP68	381	Q76N32
MIEWALGGFQPSGPK	DNMT3A	406	Q9Y6K1
WGNLPGMNRPVIASK	DNMT3B	736	Q9UBC3
GVLLPLPKGACTGWM	ADIPOQ	26	Q15848
MVGTKLPNSVLGRIW	EHD2	476	Q9NZN4
GELWKMVRIGGQPLG	CASTOR2	261	A6NHX0
GAPALMGNVVLWKPS	ALDH4A1	221	P30038
GWGLPALMVIGTGSA	ADGRG3	386	Q86Y34
LMGLKSDGTPWPAVG	DPYD	741	Q12882
PMSGGWGEGKDLLLQ	APBB1	411	O00213
LPDGKVLSGSEWGNM	CFAP44	331	Q96MT7
KSILEALGPWMNSGK	MROH7	561	Q68CQ1
MWVDQARGLAKSGPG	RASSF10	466	A6NK89
IWDIGGQTIGGKMLD	RAB28	66	P51157
LQAGMEIGWLKPVIG	CRYZ	286	Q08257
GALWPGMKPESGLIQ	EYA3	121	Q99504
MPLGGRASLTPQKLW	IQCE	66	Q6IPM2
WLTASGSGARILGPM	MFSD8	456	Q8NHS3
SGWGLLANGRMPTVL	KLK4	151	Q9Y5K2
TMWVIGLGLKKPDNS	PAPOLB	436	Q9NRJ5
LGNSLMAPVGRWQKG	MMTAG2	31	Q9BU76
LKKMREIIGWPGGSG	GAD2	221	Q05329
QLLGLLMLWVPGSSG	IGKV2D-30	6	A0A075B6S6
VAIGLAWTPLGGEIM	LONP2	656	Q86WA8
ISRGLALKMSPWASG	LFNG	261	Q8NES3
PWGPSGQLMGEIAKA	CLINT1	36	Q14677
AGWALVLAGTGIGLM	KCNN4	26	O15554
LIGMKGIGWLALRSP	NRAP	1416	Q86VF7
LGSGTWPSAPKMFLL	KLK14	6	Q9P0G3
LGILWVKMGKPSAPQ	LEMD2	226	Q8NC56
PDKWELLQLGSGGGM	GPC5	476	P78333
TLMWLKDGNPVSPAG	HMCN2	2016	Q8NDA2
PGKMLAMGALAGFWI	ARSJ	21	Q5FYB0
LKGGPLGEMVQWADI	MGAT5B	306	Q3V5L5
LGLAAPWVGTLMGTK	MFSD6L	41	Q8IWD5
QLLGLLMLWVPGSSG	IGKV2D-24	6	A0A075B6R9
LKEAGSPGLALVMWA	SLC7A5P1	76	Q8MH63
LMVGLPGSGKTQWAL	HNRNPUL2	456	Q1KMD3
ATLWMFGGLGLPQGL	MEGF8	1521	Q7Z7M0
KPGWALTPQGLAAML	LKAAEAR1	41	Q8TD35
MKTPWKVLLGLLGAA	DPP4	1	P27487
MGPGKWDGARNAILT	FMO6P	481	O60774
VQQAPGKGLEWMGLV	IGHV1-69-2	56	A0A0G2JMI3
SSVPQMLINLWGPGK	OR2C1	76	O95371
MLINLWGPGKTISYG	OR2C1	81	O95371
NWALSMGGKVPVSEG	HUWE1	1171	Q7Z6Z7
WGKSMEILPVGTLNV	OSBPL6	701	Q9BZF3
GWTILLTLTMGQGEP	HCP5	41	Q6MZN7
SLGWTMLVNRFLGPK	MFN2	546	O95140
PSLTLFGGKPMEGWI	MED16	166	Q9Y2X0
GEWAEAMLPTLGKVG	MIB1	356	Q86YT6
WEPSKNTLIMGLGTQ	MIB1	731	Q86YT6
SPKPLLTGLMWAQQG	MOGS	111	Q13724
LKWEMQLPGASQGLT	PAX4	231	O43316
LGRGGLKKSMAWDLP	ARHGAP6	126	O43182
TADWVLPGKKMGNLS	NCOA4	536	Q13772
AMQPWQPLGTKSILG	GAL3ST1	361	Q99999
GSGWLIKGMDQGLLG	FKBP10	206	Q96AY3
RNVTAIQGPGGKWMI	IDH3A	66	P50213
MWKSPNGTIRNILGG	IDH1	91	O75874
MWKSPNGTIRNILGG	IDH2	131	P48735
LPTWGKVGLGLAGTM	IGSF5	261	Q9NSI5
EMVKGLAPLQATVWG	C2CD3	1011	Q4AC94
MALSPWTPGLGAGEK	CCDC175	1	P0C221
EKSWPVMLVGNAGTG	DNAH17	2446	Q9UFH2
WGIMGTVLLTGGLKQ	ELOVL3	86	Q9HB03
LPAGLGSVRSWMQGA	EBF4	21	Q9BQW3
GMVTLTPNKGVWVNG	FCGBP	5301	Q9Y6R7
TGPGKWEGARNAIMT	FMO1	476	Q01740
LLIFSSISWMGGKNP	TMEM30B	301	Q3MIR4
SISWMGGKNPFLGIA	TMEM30B	306	Q3MIR4
MWLKVGGLLRGTGGQ	COQ8B	1	Q96D53
QGFKVWMGPISPLLS	CYP4F2	86	P78329
ILSTISWMGGKNPFL	TMEM30A	311	Q9NV96
SMGPKKVGTLWREAG	EIF4G1	1386	Q04637
WGVNPGMAISGVLLV	MS4A8	176	Q9BY19
GIPWALLNMKSGIGR	MAN1A1	321	P33908
TGIPWAMVNLKSGVG	MAN1A2	306	O60476
PWQSGVLAIGGGMKD	CDC20B	411	Q86Y33
WPSLTLLGGALIVGM	KCNMB3	216	Q9NPA1
DGLALGMGQGLKAWP	KIRREL1	56	Q96J84
ISLGAPWGGSIKPML	LCAT	231	P04180
PWGGSIKPMLVLASG	LCAT	236	P04180
QLLGLLMLWVPGSSG	IGKV2-24	6	A0A0C4DH68
QLLGLLMLWVPGSSG	IGKV2-30	6	P06310
GIWSSGVDMLPNGAV	LINC01560	36	Q8TB33
MAPSLWKGLVGIGLF	MMGT1	1	Q8N4V1
GGKMVAFAGWSLPVQ	AMT	46	P48728
LLIWSPGKGKVMVAA	HPS6	216	Q86YV9
RTGWLVGNTGVLLGM	SLC12A8	61	A0AV02
KMPWNIVLLLGGGYA	SLC13A2	416	Q13183
SKGHIWKLMGLIGGI	SLC39A12	441	Q504Y0
MGTSILSIPWGIKQA	SLC38A9	131	Q8NBW4
MGLGQPQAWLLGLPT	MFSD13A	1	Q14CX5
PGMWERTITIGSAGK	KYAT3	266	Q6YP21
GRGPILPGTKAWMET	PRAP1	81	Q96NZ9
GSMVILSQGQWMGLP	OSGIN1	136	Q9UJX0
ASGRESLKMGIGWKP	PCARE	786	A6NGG8
MVGLPAAGKTTWAIK	HNRNPUL1	426	Q9BUJ2
GTVLGIKNLSDIGWP	MAP3K4	411	Q9Y6R4
MNIKGSPWKGSLLLL	PRL	1	P01236
WKGVLMVGPPGTGKT	KATNAL1	241	Q9BW62
MAGLGLGSAVPVWLA	RNF135	1	Q8IUD6
QTLPVMSGEALGWLG	SOHLH1	251	Q5JUK2
GGLGVWKLAPMFKGV	SLC6A1	111	P30531
FGGGTTPMLTWLQIR	SLC9A9	476	Q8IVB4
GKNMAPLEALVWGVG	TMEM170B	101	Q5T4T1
GGELWGVDIPLKQLM	PIWIL2	726	Q8TC59
MGSHKTQRLLSGPWV	NBEAL2	2441	Q6ZNJ1
SLKLDMNPGTGIWQS	MSTN	191	O14793
KPWAVYAGLLGGVIM	SLAMF1	236	Q13291
LLLPLLWGTKGMEGD	SIGLEC8	6	Q9NYZ4
MTASQGPCALLWKGG	SPATA31E1	1161	Q6ZUB1
GSSGWPTMVLVLPGN	MYCBP2	2101	O75592
KGLSMNWVKGPIAVG	SLC25A42	286	Q86VD7
MLLVRGVTLPGAWKG	SLC6A7	256	Q99884
EMGIGGVLGLLWFQK	ACLY	866	P53396
GQKMPLIGLGTWKSE	AKR1A1	11	P14550
NSVSTGLMRPPWLKG	CHST1	281	O43916
TPLKLIDSWMGKGAA	RECQL	511	P46063
WMVPGSAGLLRLSAG	TCERG1L	41	Q5VWI1
PGLRVTVMLGGSWLQ	PPOX	361	P50336
LTLALLGGPTWAGKM	ZG16B	41	Q96DA0
MAAPKGSLWVRTQLG	TMEM59	1	Q9BXS4
LLITGGLMPSDGSNW	TM2D2	196	Q9BX73
TAVGRTAGWNIPMGL	TF	471	P02787
MGSPGMVLGLLVQIW	TMIGD2	1	Q96BF3
IKNLSGWMGRTGPGF	RNF112	431	Q9ULX5
GLWLGMAKLGVEAAL	SLC27A4	141	Q6P1M0
TSKPMVLFLGPWSVG	SRL	91	Q86TD4
VLFLGPWSVGKSTMI	SRL	96	Q86TD4
PLWKSVIGGMMAGVI	SLC25A27	126	O95847
GLMTGLILKLPLWGQ	RHAG	376	Q02094
SPMGWAGPLALGLLT	TMDD1	211	P0DPE3
PEGSLGWVLPNTAMK	RRAGB	26	Q5VZM2
TSGMLISVLGIWVPG	TMEM171	121	Q8WVE6
SWGEGLVTAQRGMLP	PLEKHH1	281	Q9ULM0
GGTTPMLSWLNIRVG	SLC9A7	526	Q96T83
GAIAKAIGFPWLMTI	SLC18A2	441	Q05940
GSKGMNQVPGRLLLW	WDR91	531	A4D1P6
GTTLGGNVLIWPMEG	UGT2A1	16	P0DTE4
QGKEPWMVSRDVLGG	ZNF850	61	A8MQ14
SMVKLIGITGHGIPW	PLPP7	111	Q8NBV4
TKKVHLWGMCGPLLG	ZNF776	86	Q68DI1
FMKGIGWLPLGSLEA	NEB	1931	P20929